Drug intelligence / Profile preview

chimu fuyanning

Development stage
Unknown
Lead developer
Wuhan Pharmaceutical Valley Technology Development
Modality
Metabolically Activated Prodrugs → Prodrugs/Conditional Activator Small Molecules → Small Molecules, Classical Binding Small Molecules → Small Molecules
Administration
Oral
01

Overview

Chimu Fuyanning is a Traditional Chinese Medicine (TCM) capsule developed by Wuhan Pharmaceutical Valley Technology Development Co., Ltd. for the treatment of sequelae of pelvic inflammatory disease (SPID). The formulation is specifically indicated for patients presenting with the damp-heat and blood stasis syndrome (湿热瘀阻证), a common TCM diagnosis for chronic pelvic inflammation. It functions by clearing heat, resolving dampness, and activating blood circulation to alleviate pain and inflammation. The drug has been evaluated in multi-center, randomized, double-blind, placebo-controlled clinical trials in China (e.g., CTR20132127) to establish its safety and efficacy, as well as to explore optimal clinical dosing.

Brand names
Chimu Fuyanning
Other names
Chimu Fuyanning Capsule赤母妇炎宁胶囊

Beyond the preview

Go deeper on chimu fuyanning.

Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.

Clinical trials

Full profile access

Follow clinical development from study design and recruitment through results.

  • Trial phase
  • Status
  • Readouts

Indications & development

Full profile access

Explore development by indication, patient population, and geography.

  • Indications
  • Development status
  • Countries

Licensing & deals

Full profile access

Trace asset ownership, licensing agreements, and commercial partnerships.

  • Partners
  • Deal terms
  • Milestones

Patents & exclusivity

Full profile access

Explore the patent landscape and regulatory exclusivity around an asset.

  • Patents
  • Expiration dates
  • Exclusivity

Competitive landscape

Full profile access

Compare development programs by target, modality, and indication.

  • Competing assets
  • Targets
  • Development stage

Research & analysis

Full profile access

Connect source evidence and development news to your research questions.

  • Publications
  • News
  • Analysis

Bring the full picture into focus.

See how Gosset can support your research on chimu fuyanning.

Explore the full profile

Gosset Free

Get started with Gosset.

Enter your work email and we’ll be in touch with next steps.

Work email preferred.

Book a call